Explore our catalog of highly validated Respiratory Syncytial Virus Fusion (F) Glycoprotein antibodies suitable for ELISA. Our product range includes monoclonal and recombinant Respiratory Syncytial Virus Fusion (F) Glycoprotein antibodies.
Palivizumab Biosimilar - Anti-Respiratory Syncytial Virus Fusion (F) Glycoprotein Antibody - Low endotoxin, Azide free (A323648) | |
100µg/$325 | |
| Description: | Recombinant humanized monoclonal antibody to Respiratory Syncytial Virus Fusion (F) Glycoprotein. |
| Applications: | ELISA, FACS, Functional Assay, In Vivo |
| Reactivity: | HRSV-A |
| Conjugate: | Unconjugated |
Motavizumab Biosimilar - Anti-Respiratory Syncytial Virus Fusion (F) Glycoprotein Antibody - Low endotoxin, Azide free (A323589) | |
100µg/$325 | |
| Description: | Recombinant humanized monoclonal antibody to Respiratory Syncytial Virus Fusion (F) Glycoprotein. |
| Applications: | ELISA, FACS, Functional Assay, In Vivo |
| Reactivity: | HRSV-A |
| Conjugate: | Unconjugated |
Showing 1-2 of 2 products
